Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Clasificación en acciones #17187
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Precio por acción
$2.20
Última sincronización: 2026-09-01
Capitalización bursátil
$253.81M
Cambio (1 día)
10.29%
Cambio (1 año)
99.67%
País
CA
Comercio Cardiol Therapeutics Inc. (CRDL)

Categoría

Precio CRDL con Capital del mercado a B
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
CRDL
$2.20
Capitalización de mercado de Cardiol Therapeutics Inc.(CRDL)
Capitalización bursátil: $253.81M
A fecha de September 2026, Cardiol Therapeutics Inc. tiene una capitalización de mercado de $253.81M. Esto convierte a Cardiol Therapeutics Inc. en la 17187th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Cardiol Therapeutics Inc. desde 2018 hasta 2026
CRDL en comparación con los más populares 5 títulos stocks
Precio por CRDL Activo B Capital del mercado en B Resultados
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$45,627.72 $253.81M
$5.260T +2,072,181.83%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$41,454.31 $253.81M
$4.779T +1,882,637.41%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$34,845.69 $253.81M
$4.017T +1,582,492.63%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$32,265.44 $253.81M
$3.719T +1,465,304.86%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$23,719.85 $253.81M
$2.734T +1,077,188.17%